EAU 2011 - Risk patterns of fractures and cardiovascular and thromboembolic disease, following prostate cancer treatment: Results from the population-based PCBaSe Sweden - Session Highlights

VIENNA, AUSTRIA (UroToday.com) - Androgen deprivation therapy (ADT) increases prostate cancer (CaP) patients’ risks for fractures, cardiovascular, and thromboembolic disease (CVD and TED).

Little is known about the risk of multiple events, while the time to first event is well documented.

PCBaSe Sweden is based on the National Prostate Cancer Register, which covers >96% of CaP cases in Sweden. The number of fracture, stroke, CVD, and TED events that occurred after CaP diagnosis stratified by treatment group (ADT, curative treatment, or surveillance) and history of previous event(s) was assessed.

The analysis included 76,000 men diagnosed between 1997 and 2007, of whom 30,642 men received primary ADT, 26,432 curative treatment, and 19,526 surveillance. Mean follow up time was 4.1 years. 75% of all men did not have any event during follow-up, 17% had one event and 9% had more than one event. The incidence of any event was 10/100 person-years. The proportion of men with an event was largest among men on ADT treated patients and men on surveillance. Patients having an adverse event prior to diagnosis correlated with greater likelihood to develop another event after diagnosis. Of men who had a fracture (n=3,959) after CaP diagnosis, 64% had one fracture, 8% had several fractures, and 28% had one fracture combined with other events. Among men who had a stroke (n=4,879) 63% had one stroke, 9% developed several strokes, and 28% had one stroke combined with other events. Of men who had a CVD (n=10,589) 58% had one CVD (58%), 29% had several CVDs, and 13% had one CVD combined with other events. Of men who had a TED (n=1,589) 64% had one TED, 5% had several TEDs, and 31% had one TED combined with other events. When comparing demographic and tumor characteristics between those with 1, 2, or 3+ events after CaP diagnosis, there were no clear differences between patients. Multiple events occurred after all types of primary events, but more men had a HD prior to CaP diagnosis in the group with 2 or 3+ events than those with 1 event (36, 48, and 28%, respectively).

They conclude that among the 25% of men having one event, about one-third have a second event. Apart from a history of similar adverse events prior to CaP diagnosis, no particular variables were found for men who experienced multiple events.

 

Presented by Jan Adolfsson, MD, et al. at the 26th Annual European Association of Urology (EAU) Congress - March 18 - 21, 2011 - Austria Centre Vienna, Vienna, Austria


 

The opinions expressed in this article are those of the UroToday.com Contributing Medical Editor and do not necessarily reflect the viewpoints of the European Association of Urology (EAU)


 



View EAU 2011 Annual Meeting Coverage



E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe